deltatrials
Completed PHASE3 NCT00199173

Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only

Comparison Hepatic Intra-arterial Injection of Yttrium-90 Versus 5FU in Colorectal Cancer Metastatic to the Liver Only

Sponsor: Jules Bordet Institute

Conditions Colorectal Neoplasm Secondary Malignant Neoplasm of Liver
Interventions SIR Spheres intra-arterial hepatic
Updated 5 times since 2017 Last updated: Feb 23, 2011 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

This PHASE3 trial investigates Colorectal Neoplasm and Secondary Malignant Neoplasm of Liver and is currently completed. Jules Bordet Institute leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jules Bordet Institute
  • University Hospital, Ghent
Data source: Jules Bordet Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Brussels, Belgium